# MANS-NRIZ Trial for COVID-19 Treatment : Extension Study

> **NCT04959786** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Mansoura University** · enrollment: 100 (estimated)

## Conditions studied

- COVID-19 Pneumonia

## Interventions

- **DRUG:** Ivermectin,ribavirin ,nitazoxanide and zinc

## Key facts

- **NCT ID:** NCT04959786
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2022-11
- **Final completion:** 2022-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04959786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04959786, "MANS-NRIZ Trial for COVID-19 Treatment : Extension Study". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT04959786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*